Thermosome Receives Regulatory Approval for First-In-Human Trial with its Lead Program THE001 -   Novel compound for targeted tumor therapy to be evaluated in patients with soft tissue sarcoma-   First patients to be enrolled in Q2, 2023 Munich, Germany – March 28, 2023 – Thermosome, a...